Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE:300026)
3.610
+0.040 (1.12%)
At close: Feb 3, 2026
Tianjin Chase Sun Pharmaceutical Co.,Ltd Company Description
Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of various pharmaceutical products in China and internationally.
The company provides Chinese medicine formula granules, finished drugs, raw materials, medical devices and excipients, medical and health services, as well as smart supply chain for pharmaceuticals and medical devices.
It serves the fields of immunity, cardiovascular and cerebrovascular diseases, respiratory system, and neurodegenerative diseases.
The company was founded in 1996 and is headquartered in Tianjin, China.
Tianjin Chase Sun Pharmaceutical Co.,Ltd
| Country | China |
| Founded | 1996 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 5,297 |
| CEO | Wu Jun Lan |
Contact Details
Address: Building B01, Entrepreneurial Headquarters Base Tianjin, 301700 China | |
| Phone | 86 22 5962 3160 |
| Website | chasesun.cn |
Stock Details
| Ticker Symbol | 300026 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100000GF1 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Wu Jun Lan | Vice Chairman and GM |
| Wu Sun | Executive Vice President, Chief Financial Officer, Chief Accountant and Director |
| Rui Qiang Chen | Deputy General Manager |
| Chun Xu Li | Deputy GM and Director |
| Yi Yang | Secretary of the Board of Directors |
| Kun Zhang | Deputy General Manager |
| Xiao Zhong Lu | Deputy General Manager |